Pzena Investment Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $302K | Sell |
2,511
-813
| -24% | -$93.9K | ﹤0.01% | 148 |
|
|
2025
Q4 | $350K | Hold |
3,324
| – | – | ﹤0.01% | 145 |
|
|
2025
Q3 | $279K | Hold |
3,324
| – | – | ﹤0.01% | 147 |
|
|
2025
Q2 | $263K | Buy |
+3,324
| New | +$264K | ﹤0.01% | 146 |
|
|
2025
Q1 | – | Sell |
-2,898
| Closed | -$288K | – | 158 |
|
|
2024
Q4 | $288K | Buy |
+2,898
| New | +$299K | ﹤0.01% | 145 |
|
|
2022
Q4 | – | Sell |
-6,425
| Closed | -$553K | – | 187 |
|
|
2022
Q3 | $553K | Sell |
6,425
-710
| -10% | -$63.4K | ﹤0.01% | 148 |
|
|
2022
Q2 | $650K | Buy |
7,135
+2,043
| +40% | +$181K | ﹤0.01% | 137 |
|
|
2022
Q1 | $418K | Sell |
5,092
-1,793
| -26% | -$141K | ﹤0.01% | 162 |
|
|
2021
Q4 | $528K | Sell |
6,885
-734
| -10% | -$58.5K | ﹤0.01% | 153 |
|
|
2021
Q3 | $572K | Hold |
7,619
| – | – | ﹤0.01% | 144 |
|
|
2021
Q2 | $593K | Sell |
7,619
-1,337
| -15% | -$99.4K | ﹤0.01% | 142 |
|
|
2021
Q1 | $659K | Buy |
+8,956
| New | +$661K | ﹤0.01% | 150 |
|
|
2020
Q2 | – | Sell |
-26,827
| Closed | -$1.97M | – | 176 |
|
|
2020
Q1 | $1.97M | Sell |
26,827
-34,807
| -56% | -$2.74M | 0.01% | 134 |
|
|
2019
Q4 | $5.35M | Sell |
61,634
-744,720
| -92% | -$61.2M | 0.03% | 124 |
|
|
2019
Q3 | $64.8M | Sell |
806,354
-517,515
| -39% | -$41.5M | 0.35% | 63 |
|
|
2019
Q2 | $106M | Sell |
1,323,869
-678,918
| -34% | -$52M | 0.56% | 51 |
|
|
2019
Q1 | $159M | Sell |
2,002,787
-1,854,866
| -48% | -$139M | 0.86% | 39 |
|
|
2018
Q4 | $281M | Sell |
3,857,653
-1,191,359
| -24% | -$84.1M | 1.64% | 27 |
|
|
2018
Q3 | $342M | Sell |
5,049,012
-90,732
| -2% | -$5.78M | 1.66% | 26 |
|
|
2018
Q2 | $298M | Buy |
5,139,744
+398,141
| +8% | +$22.5M | 1.5% | 27 |
|
|
2018
Q1 | $246M | Buy |
4,741,603
+3,022,334
| +176% | +$163M | 1.25% | 30 |
|
|
2017
Q4 | $92.3M | Buy |
1,719,269
+126,352
| +8% | +$7M | 0.45% | 57 |
|
|
2017
Q3 | $97.3M | Buy |
1,592,917
+728,380
| +84% | +$44.2M | 0.51% | 55 |
|
|
2017
Q2 | $52.9M | Sell |
864,537
-1,355
| -0.2% | -$82.5K | 0.29% | 79 |
|
|
2017
Q1 | $52.5M | Sell |
865,892
-455,482
| -34% | -$27.6M | 0.3% | 81 |
|
|
2016
Q4 | $74.2M | Sell |
1,321,374
-154,921
| -10% | -$9.07M | 0.42% | 61 |
|
|
2016
Q3 | $87.9M | Sell |
1,476,295
-7,034
| -0.5% | -$411K | 0.54% | 51 |
|
|
2016
Q2 | $81.5M | Buy |
1,483,329
+517,738
| +54% | +$27.6M | 0.51% | 51 |
|
|
2016
Q1 | $48.7M | Buy |
+965,591
| New | +$47.3M | 0.3% | 76 |
|
Other funds holding MRK
VCM
VPM
Pzena Investment Management's MRK Position: Q1 2026 in Review
Pzena Investment Management reduced its Merck (MRK) stake by 24% in Q1 2026, selling an estimated $93.9K and leaving 2,511 shares worth $302K. The position accounts for ﹤0.01% of the portfolio, ranked #148.
Pzena Investment Management first reported a position in MRK in Q1 2016 and has held it in 29 quarters since. The position peaked at $342M in Q3 2018. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Pzena Investment Management held 2,511 shares of Merck worth $302K as of Q1 2026.
- Pzena Investment Management sold 813 Merck shares in Q1 2026, an estimated $93.9K.
- Merck made up ﹤0.01% of Pzena Investment Management's portfolio in Q1 2026, its #148 holding.
- Pzena Investment Management first reported a position in Merck in Q1 2016 and has held it in 29 quarters since.
- Pzena Investment Management's Merck position peaked at $342M in Q3 2018.
- 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Pzena Investment Management's 13F filing for Q1 2026, filed 24 Apr 2026.